What Is CJC-1295? How It Works, Benefits & What to Expect

How CJC-1295 Works

CJC-1295 binds to GHRH receptors on the anterior pituitary gland — the same receptors that respond to naturally produced growth hormone-releasing hormone from the hypothalamus. This binding triggers the pituitary to release growth hormone into the bloodstream in a pattern that mirrors the body's own secretory activity.

The key distinction from sermorelin is the DAC modification. CJC-1295 with DAC contains a chemical linkage that allows the peptide to bind to albumin — the most abundant protein in blood plasma. This albumin binding protects CJC-1295 from enzymatic degradation, extending its half-life from the minutes seen with native GHRH to approximately 8 days. The result is a sustained elevation of GH-releasing signal rather than a brief pulse.

Growth hormone released by the pituitary then stimulates the liver to produce IGF-1 (insulin-like growth factor 1), which mediates most of GH's downstream effects: muscle protein synthesis, fat metabolism, tissue repair, cellular regeneration, and collagen production. The CJC-1295 effect operates through this entirely natural GH-IGF-1 axis — it amplifies the body's own hormonal output rather than replacing it.

For the complete mechanistic breakdown including the DAC modification and how it differs from CJC-1295 without DAC, see Complete Guide to CJC-1295 Peptide Therapy → and Peptide Synergy: CJC-1295 & Growth Hormone Therapy →.

CJC-1295 with DAC vs Without DAC

CJC-1295 exists in two forms, and understanding the difference is important for protocol design.

CJC-1295 with DAC binds to albumin and has an approximately 8-day half-life, enabling once-weekly or even once-every-10-days dosing. It produces sustained, stable GH elevation throughout the week.

CJC-1295 without DAC (also called Modified GRF 1-29) does not have the albumin-binding modification. Its half-life is approximately 30 minutes — similar to native GHRH. Without DAC, the peptide produces a more pulsatile, shorter-duration GH response and must be injected more frequently, typically 1–3 times daily. It is often combined with ipamorelin in multi-injection protocols.

Your physician determines which form is appropriate based on your goals, lifestyle, and dosing preference. For the full comparison including how to choose between CJC-1295 formulations and other GHRH options, see How to Choose CJC-1295 vs. Other Peptide Options →.

What CJC-1295 Is Used For?

CJC-1295's sustained GH elevation supports a broad range of health and performance goals that all converge on growth hormone's downstream effects through the GH-IGF-1 axis.

1. Body composition

Increased lean muscle mass, reduced adipose tissue (particularly visceral fat), and improved fat-to-muscle ratio as GH and IGF-1 drive anabolic and lipolytic processes simultaneously. See Benefits →.

2. Recovery and tissue repair

GH and IGF-1 accelerate muscle repair, connective tissue regeneration, and cellular recovery from physical stress — reducing downtime between training sessions and supporting healing from injury.

3. Sleep quality

GH secretion peaks during deep slow-wave sleep. CJC-1295's sustained GH elevation reinforces and deepens this natural GH release pattern, improving sleep depth and the recovery that occurs during it. See the case study on CJC-1295's energy and sleep effects →.

4. Energy and cognitive function

IGF-1 has documented effects on neurological function including memory, cognitive processing, and mood. The energy improvements patients report reflect both better sleep quality and improved metabolic efficiency from optimized GH levels. See Peptides: Energy, Mood & Cognitive Health →.

5. Healthy aging

GH and IGF-1 both decline with age. CJC-1295 therapy as part of a healthy aging protocol addresses this decline, supporting skin collagen, bone density, muscle maintenance, and systemic cellular regeneration. See Peptide Therapy for Healthy Active Aging →.

What to Expect and When?

How to Get Started

CJC-1295 therapy through CJC-1295.com is physician-supervised and delivered to your door. Complete a short health assessment, a licensed physician reviews your information, and if appropriate prescribes a personalized CJC-1295 protocol. Your kit ships from a licensed U.S. compounding pharmacy, free, directly to your door.

For the comparison between telehealth and in-clinic options, see In-Clinic vs. Telehealth Peptide Therapy →. For clinical perspective from physicians experienced in peptide therapy, see Physician Insights & Expert Interviews →.